Effect of Different Disease-Modifying Therapies on Humoral Response to BNT162b2 Vaccine in Sardinian Multiple Sclerosis Patients

OBJECTIVES: Vaccination against COVID-19 is highly recommended to patients affected by multiple sclerosis (MS); however, the impact of MS disease-modifying therapies (DMTs) on the immune response following vaccination has been only partially investigated. Here, we aimed to elucidate the effect of DM...

Descripción completa

Detalles Bibliográficos
Autores principales: Pitzalis, Maristella, Idda, Maria Laura, Lodde, Valeria, Loizedda, Annalisa, Lobina, Monia, Zoledziewska, Magdalena, Virdis, Francesca, Delogu, Giuseppe, Pirinu, Federica, Marini, Maria Giuseppina, Mingoia, Maura, Frau, Jessica, Lorefice, Lorena, Fronza, Marzia, Carmagnini, Daniele, Carta, Elisa, Orrù, Valeria, Uzzau, Sergio, Solla, Paolo, Loi, Federica, Devoto, Marcella, Steri, Maristella, Fiorillo, Edoardo, Floris, Matteo, Zarbo, Ignazio Roberto, Cocco, Eleonora, Cucca, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8697018/
https://www.ncbi.nlm.nih.gov/pubmed/34956211
http://dx.doi.org/10.3389/fimmu.2021.781843

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8697018/
https://www.ncbi.nlm.nih.gov/pubmed/34956211
http://dx.doi.org/10.3389/fimmu.2021.781843

Ejemplares similares